Sector: MedicalElan Corporation, plc (NYSE: ELN)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 136 |
Technical : | 22 |
Performance : | 242 |
Overall: | 125 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 139 |
Technical : | 39 |
Performance : | 253 |
Overall: | 146 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 146 |
Technical : | 288 |
Performance : | 296 |
Overall: | 287 |
Number of Stocks: | 306 |
Headlines
- TSX Venture Exchange Daily Bulletins
Nov 23, 2009 04:43 PM |
- Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 10, 2009 04:44 PM | ELN, ICLR
- Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
Oct 29, 2009 04:30 PM | ELN
- FDA Approval for Glaxo Drug
Oct 29, 2009 10:00 AM | BIIB, ELN, GSK
- Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
Oct 27, 2009 05:45 PM | BIIB, ELN
- Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
Oct 27, 2009 06:52 AM | BIIB, ELN, GENZ, GILD
- Options Intellignece Report : Microsoft (MSFT) Call Options Active, TiVo Implied Volatility Jumps
Oct 23, 2009 04:02 PM | AMZN, BRCM, ELN, MSFT, VLO
- Elan Reports Third Quarter 2009 Financial Results
Oct 21, 2009 02:00 AM | ELN, JNJ
- Elan to Highlight Tysabri Data in Crohn's Disease at the American College of Gastroenterology Annual Scientific Meeting
Oct 19, 2009 04:15 PM | BIIB, ELN
- Elan Corporation PLC Announces Results to Date of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
Oct 14, 2009 05:04 AM | ELN
- J&J posts 1 percent profit rise despite sales drop
Oct 13, 2009 01:56 PM | ELN, JNJ
- J&J posts 1 percent profit rise despite sales drop
Oct 13, 2009 11:51 AM | CRXL, ELN, JNJ
- J&J posts 1 percent profit rise despite sales drop
Oct 13, 2009 09:51 AM | CRXL, ELN, JNJ
- Bridgepoint Ed, Quiksilver, Ulta Salon big movers
Sep 04, 2009 06:09 PM | ANF, BIIB, BPI, ELN, HRB, PNR
- Relocation of Latrobe Utility Poles in Doubt
Aug 11, 2009 06:55 AM | ELN
- J&J posts lower 2Q profit, but still beats view
Jul 14, 2009 01:51 PM | CGRB, ELN, JNJ
- Stocks Tumble on Jobs News
Jul 03, 2009 10:54 AM | ACUR, AIG, CAL, DAL, ELN, EXC
- Elan, NRG Energy, Boeing are big movers
Jul 02, 2009 06:11 PM | BA, DSCO, ELN, ESLR, EXC, JNJ
- Stocks Climb on Rebound Hopes
Jun 02, 2009 11:01 AM | BMY, C, CSCO, CVX, ELN, GM
- Grand Forks Herald, N.D., Ann Bailey Column: ANN BAILEY: After a Long, Cold Winter, the Glories of Spring Beckon
Mar 29, 2009 05:54 AM | ELN
- Elan Files Declaratory Suit Against Biogen Idec; Company Has Not Breached Tysabri® Collaboration Agreement
Aug 06, 2009 10:20 AM | ELN
- Elan Drug Technologies announces first approval of a long acting injectable formulation using NanoCrystal® Technology
Aug 03, 2009 04:32 PM | ELN
- Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Aug 03, 2009 08:11 AM | ELN, JNJ
- FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Jul 31, 2009 05:21 PM | ELN
- El Nino Ventures options Bathurst project to Votorantim Metals Canada Inc.
Jul 22, 2009 10:02 AM | ELN
- Elan Reports Second Quarter 2009 Financial Results
Jul 21, 2009 02:01 AM | ELN
- Biogen Idec Reports Second Quarter 2009 Results
Jul 16, 2009 07:53 AM | ACOR, BIIB, ELN
- Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
Jul 14, 2009 09:04 AM | ELN, WYE
- Elan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
Jul 13, 2009 06:31 AM | ELN, TTHI
- Elan to Showcase Its Leadership in Alzheimer’s Disease at Upcoming International Meeting
Jul 08, 2009 08:42 AM | ELN
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ELN
|
Compare to S&P
|
| YTD |
7.67 %
|
-10.89 %
|
| 4 Weeks |
21.66 %
|
20.34 %
|
| 12 Weeks |
-12.94 %
|
-17.92 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 50.00 %
|
|
EPS Growth in Last Year: 66.67 %
|
|
Sales Growth in Last Quarter: 2.17 %
|
|
Sales Growth in Last Quarter: 6.26 %
|
|
